Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 7;12:1758835920970081. doi: 10.1177/1758835920970081

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s), 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 2. — Kaplan–Meier curves for DFS and OS according to duration of neoadjuvant ChT after excluding cT4 stage patients.

A, C: Kaplan–Meier curves of DFS according to duration of treatment (A); Kaplan–Meier curves of DFS according to duration of treatment and tumor biology (TN and HR+ BC) (C). B, D: Kaplan–Meier curves of OS according to duration of treatment (B); Kaplan–Meier curves of OS according to duration of treatment and tumor biology (TN and HR+ BC) (D). The + symbol indicates patients censored at the time of data cut-off and analysis.

BC, breast cancer; ChT, anthracycline-taxane-based chemotherapy; DFS, disease-free survival; HR+, hormone receptor-positive; OS, overall survival; TN, triple-negative.